These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 37476111)

  • 1. TJ-17 (Goreisan) mitigates renal fibrosis in a mouse model of folic acid-induced chronic kidney disease.
    Suenaga A; Seto Y; Funamoto M; Imanishi M; Tsuchiya K; Ikeda Y
    J Pharmacol Sci; 2023 Sep; 153(1):31-37. PubMed ID: 37524452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of prevention and control of delirium in ventilated patients by simulating blockage of circadian rhythm with sedative in intensive care unit].
    Li J; Dong C; Zhang H; Zhang H; Song R; Yang Z; Feng F; Qi Y; Yang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Jan; 28(1):50-6. PubMed ID: 26805535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetanus in a subcutaneous drug abuser: ineffectiveness of intrathecal baclofen.
    Thomas RM; Bellamy MC
    Anaesth Intensive Care; 2006 Dec; 34(6):811-5. PubMed ID: 17183905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Experience of Use of Kampo Medicine Shakuyakukanzoto for Muscle Spasms Caused by Tetanus.
    Oshima K; Sawada Y; Isshiki Y; Ichikawa Y; Fukushima K; Aramaki Y
    Cureus; 2023 Jun; 15(6):e40612. PubMed ID: 37476111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetanus.
    Yen LM; Thwaites CL
    Lancet; 2019 Apr; 393(10181):1657-1668. PubMed ID: 30935736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and outcomes of tetanus: Analysis using a National Inpatient Database in Japan.
    Nakajima M; Aso S; Matsui H; Fushimi K; Yasunaga H
    J Crit Care; 2018 Apr; 44():388-391. PubMed ID: 29304489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of tetanus treated with Kampo medicines such as Kakkonto and Shakuyakukanzoto.
    Nakae H; Saito Y; Okuyama M; Igarashi T
    Acute Med Surg; 2017 Apr; 4(2):217-220. PubMed ID: 29123865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015.
    Kyu HH; Mumford JE; Stanaway JD; Barber RM; Hancock JR; Vos T; Murray CJ; Naghavi M
    BMC Public Health; 2017 Feb; 17(1):179. PubMed ID: 28178973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postintensive Care Syndrome: Right Care, Right Now…and Later.
    Harvey MA; Davidson JE
    Crit Care Med; 2016 Feb; 44(2):381-5. PubMed ID: 26771784
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of concomitant use of dexmedetomidine and propofol in tetanus.
    Miya K; Shimojo N; Koyama Y; Enomoto Y; Hagiya K; Yamasaki Y; Nishino T; Kawano S; Mizutani T
    Am J Emerg Med; 2015 Dec; 33(12):1848.e3-4. PubMed ID: 25989896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of shakuyakukanzoto and its absorbed components on twitch contractions induced by physiological Ca2+ release in rat skeletal muscle.
    Kaifuchi N; Omiya Y; Kushida H; Fukutake M; Nishimura H; Kase Y
    J Nat Med; 2015 Jul; 69(3):287-95. PubMed ID: 25783410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetanus in Italy 2001-2010: a continuing threat in older adults.
    Filia A; Bella A; von Hunolstein C; Pinto A; Alfarone G; Declich S; Rota MC
    Vaccine; 2014 Feb; 32(6):639-44. PubMed ID: 24370712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antispasmodic effect of shakuyakukanzoto extract on experimental muscle cramps in vivo: role of the active constituents of Glycyrrhizae radix.
    Lee KK; Omiya Y; Yuzurihara M; Kase Y; Kobayashi H
    J Ethnopharmacol; 2013 Jan; 145(1):286-93. PubMed ID: 23164761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference.
    Needham DM; Davidson J; Cohen H; Hopkins RO; Weinert C; Wunsch H; Zawistowski C; Bemis-Dougherty A; Berney SC; Bienvenu OJ; Brady SL; Brodsky MB; Denehy L; Elliott D; Flatley C; Harabin AL; Jones C; Louis D; Meltzer W; Muldoon SR; Palmer JB; Perme C; Robinson M; Schmidt DM; Scruth E; Spill GR; Storey CP; Render M; Votto J; Harvey MA
    Crit Care Med; 2012 Feb; 40(2):502-9. PubMed ID: 21946660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of boluses of propofol for the management of severe tetanus in a child.
    Petitjeans F; Turc J; Coulet O; Puidupin M; Eve O; Benois A
    Trop Doct; 2009 Jan; 39(1):52-3. PubMed ID: 19211431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial.
    Thwaites CL; Yen LM; Loan HT; Thuy TT; Thwaites GE; Stepniewska K; Soni N; White NJ; Farrar JJ
    Lancet; 2006 Oct; 368(9545):1436-43. PubMed ID: 17055945
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.